Molbio Diagnostics has launched a new manufacturing unit for its innovative molecular diagnostic platform - Truenat Real-Time PCR, spread across 1,35,000 Sq.ft, in Verna, Goa.

The new manufacturing unit was launched in the backdrop of increasing demand for point-of-care molecular testing, in India and across the world, to meet the critical need for reliable technologies that can enable early and accurate diagnosis.

The new facility will increase the existing production capacity to 3.5 lakh units per day, thus strengthening indigenous production capacity and ensuring the uninterrupted availability of Truenat test kits.

On the occasion of the launch, Sriram Natarajan, Director & CEO of Molbio Diagnostics, said, “The demand for high-quality, point-of-care molecular diagnostic systems is higher than ever today. With this new plant, the production of Truenat kits has increased five times, from 70,000 tests per day to 3.5 lakh tests per day. The technology of Truenat will have serious implications for point of care testing in India, and the world.”

“The new facility of Molbio was conceptualised when there was a big demand for COVID tests. We developed this plant in 9 months, incorporating some of the most cutting-edge technologies in automation and manufacturing here. We hope to grow this further in the coming days” said Sangeeta Sriram, Director and Plant Incharge, Molbio Diagnostics.